These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21679008)

  • 1. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a long-term special survey.
    Iizuka T; Nishikawa Y; Mori Y; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
    Drugs R D; 2011; 11(2):191-205. PubMed ID: 21679008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
    Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor blocker; safety and efficacy in patients with hypertension) study.
    Ishimitsu T; Fukuda H; Uchida M; Ishibashi K; Sato F; Nukui K; Nagao M
    Clin Exp Hypertens; 2015; 37(7):542-50. PubMed ID: 25978131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and effectiveness of biosimilar insulin glargine in Japanese patients with diabetes mellitus in routine clinical practice: results of a post-marketing safety study.
    Shingaki T; Taki K; Koyanagi M; Nagaoka S; Yoshizawa K; Oki N; Yoshikawa A; Imaoka T
    Curr Med Res Opin; 2020 Jun; 36(6):947-958. PubMed ID: 32271092
    [No Abstract]   [Full Text] [Related]  

  • 6. Baseline characteristics and interim (3-month) efficacy and safety data from STELLA-LONG TERM, a long-term post-marketing surveillance study of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice.
    Maegawa H; Tobe K; Tabuchi H; Nakamura I
    Expert Opin Pharmacother; 2016 Oct; 17(15):1985-94. PubMed ID: 27463414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of the Russian EKSPERT program: post-marketing supervision over efficacy and influence of the preparation Ekvator on quality of life at out-patients with arterial hypertension].
    Glezer MG; Vygodin VA; Avakian AA; Prokof'eva EB
    Kardiologiia; 2014; 54(3):15-22. PubMed ID: 25102744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
    Albergati F; Paternó E; Venuti RP; Boeri D; Lombardo I; Semino S; Viviani GL; Adezati L
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S86-9. PubMed ID: 1378156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Results of ACES (Antihypertensive Combinations' Long Term Efficacy Comparing Study): Analysis of Metabolic Effects of Antihypertensive Combination Therapies.
    Nádházi Z; Dézsi CA
    Clin Drug Investig; 2016 Oct; 36(10):819-27. PubMed ID: 27405983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A post-marketing survey evaluating the safety and efficacy of a fixed-dose single-pill combination of cilnidipine and valsartan in patients with hypertension: Real-world JSH 2014 and 2019 implementations.
    Matsuda S; Nagahama S; Kurose Y; Wakabayashi M; Sugii H; Teshima T; Suzuki N; Kario K
    Clin Exp Hypertens; 2020 Aug; 42(6):502-511. PubMed ID: 31964180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
    Widmann L; van der Does R; Hörrmann M; Machwirth M
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S143-6. PubMed ID: 1974505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The KARTAN study: a postmarketing assessment of Irbesartan in patients with hypertension.
    Morales-Olivas FJ; Arístegui I; Estañ L; Rodicio JL; Moreno A; Gil V; Ferrón G; Velasco O;
    Clin Ther; 2004 Feb; 26(2):232-44. PubMed ID: 15038946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and palatability of RACTAB(®) formulation amlodipine orally disintegrating tablets.
    Fukui-Soubou M; Terashima H; Kawashima K; Utsunomiya O; Terada T
    Drugs R D; 2011 Dec; 11(4):327-36. PubMed ID: 22133388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence.
    Kuwayama Y; Hashimoto M; Kakegawa R; Nomura A; Shimada F
    Adv Ther; 2017 Jun; 34(6):1411-1425. PubMed ID: 28502035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of adding carvedilol to hypertensive patients inadequately treated with diuretics.
    Dupont AG; Schoors DF; Venuti RP
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S153-7. PubMed ID: 1974507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between cardiovascular complications and blood pressure/blood glucose control in diabetic patients with hypertension receiving long-term candesartan cilexetil therapy: Challenge-DM study.
    Kawamori R; Fujita T; Matsuoka H; Umemura S; Saito Y
    Diabetes Res Clin Pract; 2009 Feb; 83(2):241-8. PubMed ID: 19097664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic elastic properties : effects of carvedilol versus nebivolol.
    Sayin MR; Aydin M; Dogan SM; Karabag T; Cetiner MA; Aktop Z
    Herz; 2013 May; 38(3):299-305. PubMed ID: 23263241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.